Neutralizing type‐I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID‐19-Reference-Cited by-同舟云学术

Neutralizing type‐I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID‐19

Published:2021-08-08 Issue:9 Volume:99 Page:917-921
ISSN:0818-9641
Container-title:Immunology & Cell Biology
language:en
Short-container-title:Immunol Cell Biol

Author:

Abers Michael S¹^ORCID,Rosen Lindsey B¹,Delmonte Ottavia M¹,Shaw Elana¹,Bastard Paul²³^ORCID,Imberti Luisa⁴,Quaresima Virginia⁴,Biondi Andrea⁵,Bonfanti Paolo⁶,Castagnoli Riccardo¹⁷^ORCID,Casanova Jean‐Laurent²³⁸⁹,Su Helen C¹,Notarangelo Luigi D¹,Holland Steven M¹,Lionakis Michail S¹^ORCID

Affiliation:

1. Laboratory of Clinical Immunology & Microbiology National Institute of Allergy & Infectious Diseases National Institutes of Health Bethesda MD USA

2. Laboratory of Human Genetics of Infectious Diseases Necker Branch INSERM U1163 Necker Hospital for Sick Children Paris France

3. Imagine Institute University of Paris Paris France

4. CREA Laboratory Diagnostic Department ASST Spedali Civili di Brescia Brescia Italy

5. Pediatric Department and Centro Ricerca M. Tettamanti Fondazione MBBM‐Ospedale San Gerardo University of Milano‐Bicocca Monza Italy

6. Department of Infectious Diseases San Gerardo Hospital University of Milano‐Bicocca Monza Italy

7. Department of Pediatrics Fondazione IRCCS Policlinico San Matteo University of Pavia Pavia Italy

8. St. Giles Laboratory of Human Genetics of Infectious Diseases Rockefeller Branch The Rockefeller University New York NY USA

9. Howard Hughes Medical Institute New York NY USA

Funder

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Fondation pour la Recherche Médicale

Agence Nationale de la Recherche

National Human Genome Research Institute

National Institutes of Health

National Center for Advancing Translational Sciences

Regione Lombardia

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imcb.12495

Reference13 articles.

1. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

2. Longitudinal single‐cell epitope and RNA‐seq reveals the immunological impact of type 1 interferon autoantibodies in critical COVID‐19;Wijst MVS;Sci Transl Med,2021

3. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

4. Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2

5. Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Type I and type III interferons: From basic biology and genetics to clinical development for COVID-19 and beyond;Seminars in Immunology;2024-03

2. Evaluation of Genetic or Cellular Impairments in Type I IFN Immunity in a Cohort of Young Adults with Critical COVID-19;Journal of Clinical Immunology;2024-01-17

3. Human autoantibodies neutralizing type I IFNs: From 1981 to 2023;Immunological Reviews;2024-01-09

4. Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children;Journal of Experimental Medicine;2024-01-04

5. From Mendel to mycoses: Immuno‐genomic warfare at the human–fungus interface;Immunological Reviews;2023-12-08